4.4 Article

Chemometric approaches to improve PLSDA model outcome for predicting human non-alcoholic fatty liver disease using UPLC-MS as a metabolic profiling tool

期刊

METABOLOMICS
卷 8, 期 1, 页码 86-98

出版社

SPRINGER
DOI: 10.1007/s11306-011-0292-5

关键词

Metabolomics; Mass spectrometry; PLSDA and steatosis

资金

  1. Conselleria de Sanitat (Regional Valencian Ministry of Health) [AP-193/10]
  2. Spanish Ministry of Science and Innovation/Instituto de Salud Carlos III [CP08/00125]
  3. Conselleria d'Educacio (Regional Valencian Ministry of Education)

向作者/读者索取更多资源

An MS-based metabolomics strategy including variable selection and PLSDA analysis has been assessed as a tool to discriminate between non-steatotic and steatotic human liver profiles. Different chemometric approaches for uninformative variable elimination were performed by using two of the most common software packages employed in the field of metabolomics (i.e., MATLAB and SIMCA-P). The first considered approach was performed with MATLAB where the PLS regression vector coefficient values were used to classify variables as informative or not. The second approach was run under SIMCA-P, where variable selection was performed according to both the PLS regression vector coefficients and VIP scores. PLSDA models performance features, such as model validation, variable selection criteria, and potential biomarker output, were assessed for comparison purposes. One interesting finding is that variable selection improved the classification predictiveness of all the models by facilitating metabolite identification and providing enhanced insight into the metabolic information acquired by the UPLC-MS method. The results prove that the proposed strategy is a potentially straightforward approach to improve model performance. Among others, GSH, lysophospholipids and bile acids were found to be the most important altered metabolites in the metabolomic profiles studied. However, further research and more in-depth biochemical interpretations are needed to unambiguously propose them as disease biomarkers.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据